Literature DB >> 10694219

Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries.

N H Buus1, U Simonsen, H K Pilegaard, M J Mulvany.   

Abstract

The main purpose of the study was to clarify to which extent nitric oxide (NO) contributes to acetylcholine (ACh) induced relaxation of human subcutaneous small arteries. Arterial segments were mounted in myographs for recording of isometric tension, NO concentration and smooth muscle membrane potential. In noradrenaline-contracted arteries, ACh induced endothelium-dependent relaxations. The NO synthase inhibitor, N(G)-nitro-L-arginine (L-NOARG) had a small significant effect on the concentration-response curves for ACh, and in the presence of L-NOARG, indomethacin only caused a small additional rightward shift in the ACh relaxation. The NO scavenger, oxyhaemoglobin attenuated relaxations for ACh and for the NO donor S-nitroso-N-acetylpenicillamine (SNAP). Inhibition of guanylyl cyclase with 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline-1-one (ODQ), and inhibition of protein kinase G with beta-phenyl-1, N2-etheno-8-bromoguanosine- 3', 5'- cyclic monophosphorothioate, Rp-isomer, slightly attenuated ACh relaxation, but abolished SNAP induced relaxation. ACh induced relaxation without increases in the free NO concentration. In contrast, for equivalent relaxation, SNAP increased the NO concentration 32+/-8 nM. ACh hyperpolarized the arterial smooth muscle cells with 11.4+/-1.3 mV and 10.5+/-1.3 mV in the absence and presence of L-NOARG, respectively. SNAP only elicited a hyperpolarization of 1.6+/-0.9 mV. In the presence of indomethacin and L-NOARG, ACh relaxation was almost unaffected by lipoxygenase inhibition with nordihydroguaiaretic acid, or cytochrome P450 inhibition with 17-octadecynoic acid or econazole. ACh relaxation was strongly reduced by the combination of charybdotoxin and apamin, but small increments in the extracellular potassium concentration induced no relaxations. The study demonstrates that the NO/L-arginine pathway is present in human subcutaneous small arteries and to a limited extent is involved in ACh induced relaxation. The study also suggests a small contribution of arachidonic acid metabolites. However, ACh relaxation is mainly dependent on a non-NO, non-prostanoid endothelium dependent hyperpolarization. British Journal of Pharmacology (2000) 129, 184 - 192

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694219      PMCID: PMC1621136          DOI: 10.1038/sj.bjp.0703041

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

Review 1.  Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue.

Authors:  D R Harder; A R Lange; D Gebremedhin; E K Birks; R J Roman
Journal:  J Vasc Res       Date:  1997 May-Jun       Impact factor: 1.934

2.  Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries.

Authors:  B K Kemp; T M Cocks
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

3.  Vascular biology. Old-timer makes a comeback.

Authors:  P M Vanhoutte
Journal:  Nature       Date:  1998-11-19       Impact factor: 49.962

Review 4.  Endothelium-derived hyperpolarizing factor(s): updating the unknown.

Authors:  J V Mombouli; P M Vanhoutte
Journal:  Trends Pharmacol Sci       Date:  1997-07       Impact factor: 14.819

5.  Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery.

Authors:  R A Cohen; F Plane; S Najibi; I Huk; T Malinski; C J Garland
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

6.  Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans.

Authors:  S J Duffy; B T Tran; G New; R N Tudball; M D Esler; R W Harper; I T Meredith
Journal:  Am J Physiol       Date:  1998-04

7.  Human coronary arteriolar dilation to arachidonic acid depends on cytochrome P-450 monooxygenase and Ca2+-activated K+ channels.

Authors:  H Miura; D D Gutterman
Journal:  Circ Res       Date:  1998-09-07       Impact factor: 17.367

8.  Importance of endothelium-derived hyperpolarizing factor in human arteries.

Authors:  L Urakami-Harasawa; H Shimokawa; M Nakashima; K Egashira; A Takeshita
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

9.  Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients.

Authors:  S Taddei; A Virdis; L Ghiadoni; P Mattei; A Salvetti
Journal:  J Hypertens       Date:  1998-04       Impact factor: 4.844

10.  Pharmacologic activation of the human coronary microcirculation in vitro: endothelium-dependent dilation and differential responses to acetylcholine.

Authors:  F J Miller; K C Dellsperger; D D Gutterman
Journal:  Cardiovasc Res       Date:  1998-06       Impact factor: 10.787

View more
  18 in total

1.  The role of gap junctions in mediating endothelium-dependent responses to bradykinin in myometrial small arteries isolated from pregnant women.

Authors:  Louise C Kenny; Philip N Baker; David A Kendall; Michael D Randall; William R Dunn
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

2.  Activation of endothelial and epithelial K(Ca) 2.3 calcium-activated potassium channels by NS309 relaxes human small pulmonary arteries and bronchioles.

Authors:  Christel Kroigaard; Thomas Dalsgaard; Gorm Nielsen; Britt E Laursen; Hans Pilegaard; Ralf Köhler; Ulf Simonsen
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Evidence of microvascular dysfunction in patients with cystic fibrosis.

Authors:  Paula Rodriguez-Miguelez; Jeffrey Thomas; Nichole Seigler; Reva Crandall; Kathleen T McKie; Caralee Forseen; Ryan A Harris
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-15       Impact factor: 4.733

4.  Mechanisms of acetylcholine-mediated vasodilatation in young and aged human skin.

Authors:  Lacy A Holowatz; Caitlin S Thompson; Christopher T Minson; W Larry Kenney
Journal:  J Physiol       Date:  2005-01-20       Impact factor: 5.182

5.  Different modulation by Ca2+-activated K+ channel blockers and herbimycin of acetylcholine- and flow-evoked vasodilatation in rat mesenteric small arteries.

Authors:  Michael Thorsgaard; Vanesa Lopez; Niels H Buus; Ulf Simonsen
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

6.  Nitric oxide and prostaglandin inhibition during acetylcholine-mediated cutaneous vasodilation in humans.

Authors:  Marvin S Medow; June L Glover; Julian M Stewart
Journal:  Microcirculation       Date:  2008-08       Impact factor: 2.628

7.  Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome.

Authors:  Julian M Stewart; Marvin S Medow; Christopher T Minson; Indu Taneja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-27       Impact factor: 4.733

8.  Enzymatic activation of endothelial protease-activated receptors is dependent on artery diameter in human and porcine isolated coronary arteries.

Authors:  Justin R Hamilton; James D Moffatt; James Tatoulis; Thomas M Cocks
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

9.  The effect of nitric oxide synthase and cyclooxygenase inhibition on cutaneous microvascular reactivity.

Authors:  Helena Lenasi; Martin Strucl
Journal:  Eur J Appl Physiol       Date:  2008-05-31       Impact factor: 3.078

10.  ZP120 causes relaxation by pre-junctional inhibition of noradrenergic neurotransmission in rat mesenteric resistance arteries.

Authors:  U Simonsen; B E Laursen; J S Petersen
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.